HK1005454A1 - Pure crystalline form of refapentine - Google Patents

Pure crystalline form of refapentine

Info

Publication number
HK1005454A1
HK1005454A1 HK98104627A HK98104627A HK1005454A1 HK 1005454 A1 HK1005454 A1 HK 1005454A1 HK 98104627 A HK98104627 A HK 98104627A HK 98104627 A HK98104627 A HK 98104627A HK 1005454 A1 HK1005454 A1 HK 1005454A1
Authority
HK
Hong Kong
Prior art keywords
crystalline form
pure crystalline
refapentine
new pure
rifapentine
Prior art date
Application number
HK98104627A
Other languages
English (en)
Inventor
Emilio Occelli
Marino Nebuloni
Bruno Cavalleri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of HK1005454A1 publication Critical patent/HK1005454A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
HK98104627A 1990-06-29 1998-05-28 Pure crystalline form of refapentine HK1005454A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90112458 1990-06-29

Publications (1)

Publication Number Publication Date
HK1005454A1 true HK1005454A1 (en) 1999-01-08

Family

ID=8204159

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104627A HK1005454A1 (en) 1990-06-29 1998-05-28 Pure crystalline form of refapentine

Country Status (13)

Country Link
EP (1) EP0536197B1 (de)
JP (1) JP3350861B2 (de)
KR (1) KR0170000B1 (de)
AT (1) ATE125541T1 (de)
BG (1) BG60980B2 (de)
CA (1) CA2082809C (de)
DE (1) DE69111607T2 (de)
DK (1) DK0536197T3 (de)
ES (1) ES2075454T3 (de)
HK (1) HK1005454A1 (de)
HU (1) HU211168A9 (de)
IE (1) IE68687B1 (de)
WO (1) WO1992000302A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1279898B1 (de) 2001-07-26 2008-09-10 ALSTOM Technology Ltd Vormischbrenner mit hoher Flammenstabilität
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7262236B2 (en) 2004-04-26 2007-08-28 Milliken & Company Acetal-based compositions
PL1698630T3 (pl) 2005-03-03 2014-12-31 Alfasigma Spa Nowe postacie polimorficzne rifaksyminy,sposoby ich wytwarzania i ich zastosowanie w preparatach leczniczych
IT1397107B1 (it) * 2009-12-28 2012-12-28 Lavagna Nuovo metodo per la preparazione di antibiotici in stato amorfo e prodotti ottenuti utilizzando detto metodo.
EP2401282B2 (de) 2009-12-28 2017-01-04 Silvio Massimo Lavagna Verfahren zur herstellung von amorphem rifaximin
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CN102079749B (zh) * 2010-11-25 2012-07-04 河北欣港药业有限公司 利福平原料药≤0.3g/ml及≥0.8g/ml密度规格的生产方法
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
CN103772413B (zh) * 2014-02-07 2016-01-20 天津大学 一种利福平ⅱ晶型的制备方法
US20240199642A1 (en) * 2021-04-21 2024-06-20 Interquim S.A. De C.V. Method for obtaining rifapentine with a new crystalline form

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides

Also Published As

Publication number Publication date
ES2075454T3 (es) 1995-10-01
JPH05507690A (ja) 1993-11-04
WO1992000302A1 (en) 1992-01-09
EP0536197B1 (de) 1995-07-26
DK0536197T3 (da) 1995-11-13
JP3350861B2 (ja) 2002-11-25
EP0536197A1 (de) 1993-04-14
HU211168A9 (en) 1995-11-28
KR0170000B1 (ko) 1999-02-01
DE69111607T2 (de) 1995-12-21
KR930701448A (ko) 1993-06-11
DE69111607D1 (de) 1995-08-31
CA2082809C (en) 1995-10-17
ATE125541T1 (de) 1995-08-15
BG60980B2 (bg) 1996-07-31
IE912266A1 (en) 1992-01-01
IE68687B1 (en) 1996-07-10

Similar Documents

Publication Publication Date Title
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
IL68230A0 (en) Quaternary 6,11-dihydro-dibenzo(b,e)thiepine-11-n-alkyl-norscopine ethers,their preparation and pharmaceutical compositions containing them
HK1054500A1 (en) Process for the preparation of aerosol compositions.
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
IL98756A0 (en) Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation
HK1005454A1 (en) Pure crystalline form of refapentine
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
GB8815870D0 (en) Titanium compounds composition containing them & their preparation
HU9303113D0 (en) Pharmaceutical compositions containing 1,2-dithiol-3-thione-derivatives
IL81410A (en) Pharmaceutical compositions containing substituted n-arylmethylamine derivatives,certain such novel compounds and their preparation
IL112999A0 (en) Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
IL99637A0 (en) 5h-benzodiazepine derivative,its preparation and pharmaceutical compositions containing it
HUT48613A (en) Process for producing carbamoyloxylabdane derivatives, their intermediaries and pharmaceutical compositions comprising such compounds as active ingredient
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
IL98541A0 (en) Pyrimidinyl compounds,their preparation and pharmaceutical compositions containing them
IL74264A0 (en) Preparation of calciferol derivatives,certain such novel compounds and pharmaceutical compositions containing them
GB8908906D0 (en) Therapeutic compounds,compositions & uses thereof
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.
ES8500928A1 (es) Procedimiento para la obtencion de oxaspirododecan-derivados de efecto perfumante
HUT52111A (en) Process for producing cytidine-5'-diphosphatealkanols and -glycerine derivatives, as well pharmaceutical compositions comprising such compounds as active ingredient
IL86828A0 (en) Benzo-dipyran derivative,its preparation and pharmaceutical compositions containing it
ZA9110085B (en) The process for the preparation of enantiomerically pure thienopyran derivative.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20110604